Mergers are driving up biotech stocks, but beware of short traders. Outlook Biotech stocks? Proceed with caution
Tech stocks aren't likely to crash, but valuations are looking pricey. Outlook As Nasdaq soars, bubble fears grow
I've liquidated all my holdings in marijuana stocks for now. Strategies Up in smoke: Why I sold my marijuana stocks
After a big 2013 sector rally, Robert Freedland looks ahead to next year. Strategies Healthcare portfolio manager upbeat for 2014 as Obamacare kicks in
I bought into the fast-growing industries via two exchange traded funds. Strategies Here are my ETF picks for biotech and robotics
3D Systems is pricey but has a promising future. Strategies Core holding 3D Systems continues to deliver
Here's why we took a position in the iShares NASDAQ Biotechnology Index. Strategies Why biotech trumps big pharma in our portfolio
Philip Pecoraro shares his technical analysis Strategies Don’t get “chopped up” in the market’s increased volatility – …
